Purchase Order W81K0225PA026
Award Date
6/30/25
Potential Completion Date
9/30/25
Potential Value
$93K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
1 Jarrett White Rd, TRIPLER AMC, HI 96859, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of Urinary Pathogen ID/AMR Enrichment Kits. The $61,848.39 contract has a period of performance through September 30, 2024 and will support the use of government-owned Illumina MiSeq sequencing instruments at Tripler Army Medical Center in Hawaii. The award was made on a sole source basis under the simplified acquisition...
This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents. The $144,074.38 contract is for Illumina RNA prep with enrichment supplies to support the MiSeq system used at the Tripler Army Medical Center in Hawaii. The award was made on a sole-source basis without a set-aside, citing Illumina as the only responsible source for the proprietary sequencing technology....
The Department of the Army Medical Command awarded a $247,627.76 firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturing organization, for Illumina RNA Prep with Enrichment products and services. The contract does not have a set-aside designation. This award was made without full and open competition under the sole-source authority of FAR 13.106-1(b)(1)(i) based on Illumina's proprietary sequencing technology and status as the sole manufacturer. Illumina has a history of...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Illumina, Inc., a biotechnology company headquartered in San Diego, California. The $24,291.59 contract is for the procurement of deoxyribonucleic acid (DNA) sequencers and reagent kits to be used at Walter Reed National Military Medical Center. The contract has an ultimate completion date of June 27, 2025. Illumina, a for-profit manufacturer of goods, has been awarded multiple federal contracts and Indefinite...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $119,937.50 contract is for the procurement of replacement laboratory equipment, specifically next-generation sequencing systems and associated consumables, to support the agency's biodefense research and diagnostics efforts. Illumina has previously been awarded prime contracts and subcontracts across various federal...
This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...
The U.S. Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents, to provide MiSeq Reagent Kits for $129,820.35. This award, which has no set-aside designation, supports the agency's ongoing requirements for nucleic acid sequencing capabilities. Illumina has previously received prime federal contracts from agencies like the National Institutes of Health, Centers for...